FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135753750> ?p ?o ?g. }

• W2135753750 endingPage "6250" @default.
• W2135753750 startingPage "6243" @default.
• W2135753750 abstract "To approve a new anticancer drug, the US Food and Drug Administration often requires randomized trials. However, several oncology drugs have been approved on the basis of objective end points without a randomized trial. We reviewed the long-term safety and efficacy of such agents.We searched the Web site of the US Food and Drug Administration's Center for Drug Evaluation and Research and MEDLINE for initial applications of investigational anticancer drugs from 1973 through 2006.Overall, 68 oncology drugs, excluding hormone therapy and supportive care, were approved, including 31 without a randomized trial. For these 31 drugs, a median of two clinical trials (range, one to seven) and 79 patients (range, 40 to 413) were used per approval. Objective response was the most common end point used for approval; median response rate was 33% (range, 11% to 90%). Thirty drugs are still fully approved. United States marketing authorization for one drug, gefitinib (an epidermal growth factor receptor [EGFR] inhibitor), was rescinded after a randomized trial showed no survival improvement; however, this trial was performed in unselected patients, and it was subsequently demonstrated that patients with EGFR mutation are more likely to respond. Nineteen of the 31 drugs have additional uses (per National Comprehensive Cancer Network or National Cancer Institute Physician Data Query guidelines), and subsequent formal US Food and Drug Administration approvals were obtained for 11 of these (range, one to 18 new indications). No drug has demonstrated safety concerns.Nonrandomized clinical trials with definitive end points can yield US Food and Drug Administration approvals, and these drugs have a reassuring record of long-term safety and efficacy." @default.
• W2135753750 created "2016-06-24" @default.
• W2135753750 creator A5004805369 @default.
• W2135753750 creator A5009078484 @default.
• W2135753750 creator A5044840107 @default.
• W2135753750 creator A5053481267 @default.
• W2135753750 date "2009-12-20" @default.
• W2135753750 modified "2023-09-30" @default.
• W2135753750 title "Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial" @default.
• W2135753750 cites W1584570151 @default.
• W2135753750 cites W1926511128 @default.
• W2135753750 cites W1931508686 @default.
• W2135753750 cites W1970358033 @default.
• W2135753750 cites W1973702706 @default.
• W2135753750 cites W1978209044 @default.
• W2135753750 cites W1978242550 @default.
• W2135753750 cites W1990427543 @default.
• W2135753750 cites W1995628336 @default.
• W2135753750 cites W2004761507 @default.
• W2135753750 cites W2027097780 @default.
• W2135753750 cites W2027194634 @default.
• W2135753750 cites W2027266396 @default.
• W2135753750 cites W2037624670 @default.
• W2135753750 cites W2043103956 @default.
• W2135753750 cites W2043696829 @default.
• W2135753750 cites W2050948499 @default.
• W2135753750 cites W2073693702 @default.
• W2135753750 cites W2099015389 @default.
• W2135753750 cites W2104285913 @default.
• W2135753750 cites W2104389711 @default.
• W2135753750 cites W2107268345 @default.
• W2135753750 cites W2107304950 @default.
• W2135753750 cites W2108947370 @default.
• W2135753750 cites W2109247912 @default.
• W2135753750 cites W2122334493 @default.
• W2135753750 cites W2123095233 @default.
• W2135753750 cites W2125558775 @default.
• W2135753750 cites W2130982149 @default.
• W2135753750 cites W2131450616 @default.
• W2135753750 cites W2135358937 @default.
• W2135753750 cites W2138297714 @default.
• W2135753750 cites W2138534950 @default.
• W2135753750 cites W2138800281 @default.
• W2135753750 cites W2143989581 @default.
• W2135753750 cites W2152251876 @default.
• W2135753750 cites W2153230966 @default.
• W2135753750 cites W2153477391 @default.
• W2135753750 cites W2158134441 @default.
• W2135753750 cites W2161324454 @default.
• W2135753750 cites W2163147844 @default.
• W2135753750 cites W2164520862 @default.
• W2135753750 cites W2166517289 @default.
• W2135753750 cites W2167112387 @default.
• W2135753750 cites W2168277549 @default.
• W2135753750 cites W2328421677 @default.
• W2135753750 cites W2409420104 @default.
• W2135753750 cites W32671482 @default.
• W2135753750 cites W4293541898 @default.
• W2135753750 cites W4385789423 @default.
• W2135753750 doi "https://doi.org/10.1200/jco.2009.23.6018" @default.
• W2135753750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19826112" @default.
• W2135753750 hasPublicationYear "2009" @default.
• W2135753750 type Work @default.
• W2135753750 sameAs 2135753750 @default.
• W2135753750 citedByCount "78" @default.
• W2135753750 countsByYear W21357537502012 @default.
• W2135753750 countsByYear W21357537502013 @default.
• W2135753750 countsByYear W21357537502014 @default.
• W2135753750 countsByYear W21357537502015 @default.
• W2135753750 countsByYear W21357537502016 @default.
• W2135753750 countsByYear W21357537502017 @default.
• W2135753750 countsByYear W21357537502018 @default.
• W2135753750 countsByYear W21357537502019 @default.
• W2135753750 countsByYear W21357537502020 @default.
• W2135753750 countsByYear W21357537502021 @default.
• W2135753750 countsByYear W21357537502023 @default.
• W2135753750 crossrefType "journal-article" @default.
• W2135753750 hasAuthorship W2135753750A5004805369 @default.
• W2135753750 hasAuthorship W2135753750A5009078484 @default.
• W2135753750 hasAuthorship W2135753750A5044840107 @default.
• W2135753750 hasAuthorship W2135753750A5053481267 @default.
• W2135753750 hasConcept C121608353 @default.
• W2135753750 hasConcept C126322002 @default.
• W2135753750 hasConcept C143998085 @default.
• W2135753750 hasConcept C168563851 @default.
• W2135753750 hasConcept C203092338 @default.
• W2135753750 hasConcept C2777589142 @default.
• W2135753750 hasConcept C2779438470 @default.
• W2135753750 hasConcept C2780035454 @default.
• W2135753750 hasConcept C2780580887 @default.
• W2135753750 hasConcept C3018890749 @default.
• W2135753750 hasConcept C535046627 @default.
• W2135753750 hasConcept C60644358 @default.
• W2135753750 hasConcept C71924100 @default.
• W2135753750 hasConcept C86803240 @default.
• W2135753750 hasConcept C98274493 @default.
• W2135753750 hasConceptScore W2135753750C121608353 @default.
• W2135753750 hasConceptScore W2135753750C126322002 @default.

• next